MedTrace Logo

The Effectiveness of BreatheMAX Breathing Device on Secretion Clearance

NCT01090804 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2010-03-23

No results posted yet for this study

Summary

The purpose of this study is to determined effects of BreatheMAX on secretion clearance.

Conditions

Interventions

DEVICE

BreatheMAX breathing device

secretion clearance, breathing exercise

Sponsors & Collaborators

  • Khon Kaen University

    lead OTHER

Principal Investigators

  • Sujittra Kluayhomthong, Bachelor · Physical Therapy department, Faculty of Associated Medical Sciences, Khon Kaen university

  • Chulee CU Jones, Philosophy · Physical Therapy Department, Faculty of Associated Medical Sciences, Khon Kaen university, Thailand

  • Wilaiwan Khrisanapant, Philosophy · Department of physiology, Faculty of medicine, Khon Kaen university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
15 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2009-12-31

Countries

  • Thailand

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01090804 on ClinicalTrials.gov